Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis—a case series

Annals of the Rheumatic Diseases · Published 2026-06-01 · DOI 10.1016/j.ard.2026.05.023

Free full text

Authors (45)

Elise Siegert, Elpida Phithak, Fredrik N. Albach, Robert Biesen, Norman Michael Drzeniek, Maria Dzamukova, Isabell Haase, Klaus Søndergaard, Dorothea Schleser, Leonard Fiebig, Arne Sattler, Ioanna Minopoulou, Marie Chiara Rehm, Phillip Kremer, Udo Schneider, Sofia Trezzini, Anna Maria Claire Rein, Clara Marisa Mayer, Felix Doellinger, Christian Furth, Anja Staeck, Qingyu Cheng, Benedikt Sinzinger, Nadine Unterwalder, Sarah Ohrndorf, Meike Probst, Yaosi Li, Daniel Grund, Thula Walter-Rittel, Anja Fleischmann, Edgar Wiebe, Marie Luise Hütter-Krönke, Ulrich Keller, Jan Krönke, Antonia Busse, Arnd Kleyer, Ann-Christin Pecher, Jörg Henes, Anne Troldborg, Anja Erika Hauser, Ina Kötter, Martin Krusche, Gerhard Krönke, Tobias Alexander, David Simon

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Siegert, E., Phithak, E., Albach, F., et al. (2026). Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis—a case series. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2026.05.023

Related articles